Literature DB >> 12845649

Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients.

Olga Minenkova1, Andrea Pucci, Emiliano Pavoni, Amedeo De Tomassi, Paola Fortugno, Nicola Gargano, Maurizio Cianfriglia, Stefano Barca, Sabino De Placido, Angelo Martignetti, Franco Felici, Riccardo Cortese, Paolo Monaci.   

Abstract

Screening cDNA libraries from solid human tumors with sera of autologous patients (SEREX) has proven to be a powerful approach to identifying tumor antigens recognized by the humoral arm of the immune system. In many cases, application of this methodology has led to the discovery of novel tumor antigens as unknown gene products. We tried to improve the potency of the SEREX approach by combining it with phage-display technology. We designed a new lambda vector to express protein fragments as N-terminal fusions to the D capsid protein and generated high-complexity cDNA libraries from human breast carcinoma cell lines and solid tumors. Screening these phage-displayed libraries required limited amounts of sera from patients and efficiently identified several tumor antigens specifically reacting with sera from breast cancer patients. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845649     DOI: 10.1002/ijc.11269

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Authors:  Elisa Beghetto; Andrea Spadoni; Luca Bruno; Wilma Buffolano; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.

Authors:  Karen S Anderson; Sahar Sibani; Garrick Wallstrom; Ji Qiu; Eliseo A Mendoza; Jacob Raphael; Eugenie Hainsworth; Wagner R Montor; Jessica Wong; Jin G Park; Naa Lokko; Tanya Logvinenko; Niroshan Ramachandran; Andrew K Godwin; Jeffrey Marks; Paul Engstrom; Joshua Labaer
Journal:  J Proteome Res       Date:  2010-11-23       Impact factor: 4.466

Review 3.  The sentinel within: exploiting the immune system for cancer biomarkers.

Authors:  Karen S Anderson; Joshua LaBaer
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

4.  Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology.

Authors:  Veronica Lanza Cariccio; Maria Domina; Salvatore Benfatto; Mario Venza; Isabella Venza; Agnese Faleri; Marco Bruttini; Erika Bartolini; Marzia Monica Giuliani; Laura Santini; Brunella Brunelli; Nathalie Norais; Erica Borgogni; Angelina Midiri; Roberta Galbo; Letizia Romeo; Carmelo Biondo; Vega Masignani; Giuseppe Teti; Franco Felici; Concetta Beninati
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

5.  POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.

Authors:  Qingqing Meng; Yahong Wu; Xinghua Sui; Jingjie Meng; Tingting Wang; Yan Lin; Zhiwei Wang; Xiuman Zhou; Yuanming Qi; Jiangfeng Du; Yanfeng Gao
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

Review 6.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

Authors:  Michael A Tainsky
Journal:  Biochim Biophys Acta       Date:  2009-05-04

7.  A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda.

Authors:  Christine N Zanghi; Heather A Lankes; Birgit Bradel-Tretheway; Jessica Wegman; Stephen Dewhurst
Journal:  Nucleic Acids Res       Date:  2005-10-13       Impact factor: 16.971

8.  Autoantibodies in Early Detection of Breast Cancer.

Authors:  Femina Rauf; Karen S Anderson; Joshua LaBaer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-29       Impact factor: 4.254

9.  Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer.

Authors:  Xuejun Dong; Mingfeng Yang; He Sun; Juan Lü; Zhuan Zheng; Zhiguo Li; Li Zhong
Journal:  Onco Targets Ther       Date:  2013-03-28       Impact factor: 4.147

10.  Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).

Authors:  Liping Dai; Ningjing Lei; Mei Liu; Jian-Ying Zhang
Journal:  Exp Hematol Oncol       Date:  2013-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.